Evidence map›Paper›PMID 24849855›Full record

ArticleThe Lancet. Neurology2014

Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?

Andreas Charidimou, Hans Rolf J Jäger

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Contributing factors of spontaneous intracerebral hemorrhage development in young adults.Journal of cerebrovascular and endovascular neurosurgery · 2024
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2015
    Observational
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Andreas CharidimouStroke Research Group, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, UK. Electronic address: andreas.charidimou.09@ucl.ac.uk.
Hans Rolf J JägerLysholm Department of Neuroradiology, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK; Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersCerebral Amyloid AngiopathyHumansBiomarkers

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.